Distillations: Science + Culture + History

Our producer Rigoberto Hernandez spoke with Robin Marantz, the author of Pandora’s Baby: How the First Test Tube Babies Sparked the Reproductive Revolution. She tells us about the history of IVF, from the first known artificial insemination by donor produced in Philadelphia in the 19th century to the scientific race in the 1960s and 1970s that resulted in the first so-called “test-tube baby.” Credits Host: Alexis Pedrick Executive Producer: Mariel Carr Producer: Rigoberto Hernandez Associate Producer: Sarah Kaplan Audio Engineer: Samia Bouzid Music by Blue Dot Sessions Resource List Henig, Robin Marantz. Pandora's Baby: How the First Test Tube Babies Sparked the Reproductive Revolution. Cold Spring Harbor Laboratory Press, 2006.

When Rebekah and Evan Lockard’s daughter, Naomi, was diagnosed with a devastating ultra-rare genetic disease, they didn’t know where to turn. Then they found Terry Pirovolakis, an IT professional who had made a gene therapy for his son with the same disease. But the process of getting Naomi treated has been an uphill battle, full of financial and logistical obstacles. The Lockard’s story flips the question we’ve been asking all season on its head. Instead of wondering, "if we could do something, should we," we're now asking, "if we can do something that helps patients, should we do it at any cost?" And this question isn’t for scientists or researchers, it’s for the rest of us. Credits Host: Alexis Pedrick Executive Producer: Mariel Carr Producer: Rigoberto Hernandez Associate Producer: Sarah Kaplan Audio Engineer: Samia Bouzid Music by Blue Dot Sessions Resource List Mast, Jason. "A dad built a gene therapy for his son. Can he save other kids, too?" STAT News. Elpida Therapeutics. "Battling SPG50 and changing

Gene therapy is based on a simple-sounding, yet deceptively complicated premise: adding or replacing faulty genes to fix medical problems. A compelling idea that came out of breakthroughs in DNA research, the field grew lightning fast. But the death of teenager Jesse Gelsinger after a gene therapy clinical trial left the public and scientists questioning the field’s promise.  Why did researchers push ahead with clinical trials despite gene therapy still being  in its infancy? What does the Jesse Gelsinger story tell us about the personal risk behind medical breakthroughs? Credits Host: Alexis Pedrick Executive Producer: Mariel Carr Producer: Rigoberto Hernandez Associate Producer: Sarah Kaplan Audio Engineer: Samia Bouzid Music by Blue Dot Sessions Resource List American Experience: The Boy in the Bubble. PBS. Begley, Sharon. “Out of Prison, the ‘Father of Gene Therapy’ Faces a Harsh Reality: a Tarnished Legacy and an Ankle Monitor.” STAT News, July 23, 2018. Cobb, Matthew. As Gods: A Moral History of the Ge

Producer Mariel Carr talks to historian of science and former Science History Institute fellow, Luis Campos, about his article “Strains of Andromeda: The Cosmic Potential Hazards of Genetic Engineering." He shares how Michael Crichton’s first novel and the subsequent film influenced the conversation and controversy around recombinant DNA research in the 1970s. Credits Host: Alexis Pedrick Executive Producer: Mariel Carr Producer: Rigoberto Hernandez Associate Producer: Sarah Kaplan Audio Engineer: Samia Bouzid Music by Blue Dot Sessions Resource List The Andromeda Strain. IMDb. Campos, Luis A. "Strains of Andromeda: The Cosmic Potential Hazards of Genetic Engineering."

In 1976, Harvard University wanted to build a specialized lab for recombinant DNA research. But first, it had to get permission from the city of Cambridge. The resulting city council hearings drew TV stations and captured the attention of the whole country. At the center of the controversy? A wise-talking mayor, a young outspoken molecular biologist, and an important question: in scientific research, how much say should the public have? Credits Host: Alexis Pedrick Executive Producer: Mariel Carr Producer: Rigoberto Hernandez Associate Producer: Sarah Kaplan Audio Engineer: Samia Bouzid Resource List Cobb, Matthew.  As Gods: A Moral History of the Genetic Age. New York: Basic Books, 2021. Krimsky, Sheldon. Genetic Alchemy: A Social History of the Recombinant DNA Controversy. Cambridge: The MIT Press, 1984. Rogers, Michael. “Biohazard.” Nova: The Gene Engineers. Dailymotion. “Cambridge DNA Hearings, 1976.” Massachusetts Institute of Technology, Oral History Program, oral history collection on the recombinant

Check out our new season, dropping weekly on Tuesdays, starting August 5th.

Feeding kids a healthy lunch every school day is a feat of science and logistics. Molded into shape by nutrition scientists who wanted to optimize children’s health, the school lunch has endured war, economic depression, and even a global pandemic. Some might say it’s all the stronger for it. So how did all these crises shape school lunch? And is there any room to give our rectangle pizzas and frozen chicken patties a little grace? Credits Host: Alexis Pedrick Executive Producer: Mariel Carr Producer: Rigoberto Hernandez Associate Producer: Sarah Kaplan Audio Engineer: Jonathan Pfeffer Music by Blue Dot Sessions. Resource List 1930s Farmer Talks About the Great Depression and Poverty. YouTube video. 1:54. Posted by Timeless Footage, March 10, 2020. ABC Evening News. May 14, 1969. Vanderbilt Television News Archive. CBS News. CBS Evening News. September 4, 1981. Vanderbilt Television News Archive. CBS News. September 25, 1981. Vanderbilt Television News Archive. C-SPAN. House Session, Part 1. Daily School Mea

Genetic engineering breakthroughs in the late 1960s and early 1970s came with a lot of promise—and peril too. Fears about what could happen with recombinant DNA experiments put scientists in the middle of a moral dilemma. Did they have a responsibility to consider how  others might use their work? Or was their place simply to be on the lab bench? In this two-part episode, we’ll share the story about the first time scientists stopped and considered the ramifications of their work, with a self-imposed moratorium. And we’ll explore all the controversy that led to the historic pivotal meeting at the Asilomar Conference Grounds in 1975 to determine the future of genetic engineering. Credits Host: Alexis Pedrick Senior Producer: Mariel Carr Producer: Rigoberto Hernandez Associate Producer: Sarah Kaplan Audio Engineer: Jonathan Pfeffer Music by Blue Dot Sessions Resource List A Deep Conversation with Jon Beckwith: A History of Scientific and Social Activism. University of California Television. YouTube. Berg, Paul. 

Genetic engineering breakthroughs in the late 1960s and early 1970s came with a lot of promise—and peril too. Fears about what could happen with recombinant DNA experiments put scientists in the middle of a moral dilemma. Did they have a responsibility to consider how  others might use their work? Or was their place simply to be on the lab bench? In this two-part episode, we’ll share the story about the first time scientists stopped and considered the ramifications of their work, with a self-imposed moratorium. And we’ll explore all the controversy that led to the historic pivotal meeting at the Asilomar Conference Grounds in 1975 to determine the future of genetic engineering. Credits Host: Alexis Pedrick Senior Producer: Mariel Carr Producer: Rigoberto Hernandez Associate Producer: Sarah Kaplan Audio Engineer: Jonathan Pfeffer Music by Blue Dot Sessions Resource List A Deep Conversation with Jon Beckwith: A History of Scientific and Social Activism. University of California Television. YouTube. Berg, P

ALS is a fatal neurological disease that kills motor neurons. Even though it was first described more than 150 years ago, there is no cure, and the few drugs available only dampen the symptoms or slow the progression by a few months. In recent years new drugs have emerged. However, there is one problem: the life expectancy is just two to five years after diagnosis. This timeline is incompatible with the FDA drug approval process, which takes years and even decades. This has created a tense situation for desperate patients who are demanding the FDA approve unproven drugs. What’s the harm in giving desperate patients an imperfect drug? Credits Host: Alexis Pedrick Senior Producer: Mariel Carr Producer: Rigoberto Hernandez Associate Producer: Sarah Kaplan Audio Engineer: Jonathan Pfeffer “Color Theme” composed by Jonathan Pfeffer. Additional music by Blue Dot Sessions

In 1973 a bombshell study appeared in the premier scientific journal Science. It was called “On Being Sane in Insane Places.” Its author, a Stanford psychology professor named David Rosenhan, claimed that by faking their way into psychiatric hospitals, he and eight other pseudo-patients had proven that psychiatrists were unable to diagnose mental illness accurately. Psychiatrists panicked, and, as a result, re-wrote what’s known as “psychiatry’s bible”—the Diagnostic and Statistical Manual of Mental Disorders, or DSM. The study and the subsequent overhaul of the DSM changed the field forever. So it was a surprise when, decades later, a journalist reopened Rosenhan’s files and discovered that the study was full of inconsistencies and even blatant fraud. So should we throw out everything it revealed? Or can something based on a lie still contain any truths? Credits Host: Alexis Pedrick Senior Producer: Mariel Carr Producer: Rigoberto Hernandez Associate Producer: Sarah Kaplan Audio Engineer: Jonathan Pfef

For more than 100 years, biologists who suggested that some cancers may be caused by viruses were the pariahs of genetics. However, they persevered and incrementally built their knowledge, leading to the discovery of retroviruses, the development of a test to diagnose HIV, and the creation of the HPV vaccine. Join us as we interview Gregory J. Morgan about his book Cancer Virus Hunters: A History of Tumor Virology. Credits Host: Alexis Pedrick Senior Producer: Mariel Carr Producer: Rigoberto Hernandez Associate Producer: Sarah Kaplan Audio Engineer: Jonathan Pfeffer “Color Theme” composed by Jonathan Pfeffer. Additional music by Blue Dot Sessions Note to Our Listeners We are aware of an issue with certain podcast players displaying the incorrect length for the episode. We're looking into it and hope to have the matter resolved soon. In the meantime, the actual run time of the episode is the length displayed in the feed before pressing play. We apologize for the inconvenience. 

In 1973 biochemist Bruce Ames created a simple test that showed if chemicals had the potential to cause cancer. The Ames test made him a hero of the emerging environmental movement. But then he completely changed course and said concerns about chemicals were overblown. So what happened? Did Ames change? Or did our understanding of what causes cancer change? Featured Oral History Bruce N. Ames, "Bruce N. Ames: The Marriage of Biochemistry and Genetics at Caltech, the NIH, UC Berkeley, and CHORI, 1954–2018" conducted by Paul Burnett in 2019 and 2020, Oral History Center, The Bancroft Library, University of California, Berkeley, 2021. Credits Host: Alexis Pedrick Senior Producer: Mariel Carr Producer: Rigoberto Hernandez Associate Producer: Sarah Kaplan Audio Engineer: Jonathan Pfeffer “Color Theme” composed by Jonathan Pfeffer. Additional music by Blue Dot Sessions Note to Our Listeners We are aware of an issue with certain podcast players displaying the incorrect length for the episode. We're looking into it

Ozempic and others in this family of drugs are nothing short of miraculous. Meant to treat Type 2 Diabetes, the drug exploded in popularity after researchers found that patients were reporting losing 15-21% of their body weight in clinical trials. There were some side effects, but none so severe that it raised concerns. Doctors began prescribing it to people who weren't diabetic but could benefit from weight loss, and now, our only problem seems to be getting enough of it for all the people who need it. It all seems magical, but is it too good to be true? Join us as we dive into the history of weight loss drugs, drug manufacturing regulations, and the role we think medicine should play in our lives. Credits Host: Alexis Pedrick Senior Producer: Mariel Carr Producer: Rigoberto Hernandez Associate Producer: Sarah Kaplan Audio Engineer: Jonathan Pfeffer “Color Theme” composed by Jonathan Pfeffer. Additional music by Blue Dot Sessions Note to Our Listeners We are aware of an issue with certain podcast players dis

The impact of cars on wildlife extends beyond roadkill, affecting species that never venture near roads. Car noise disrupts bird communication and behavior, and tire and brake dust from pollutes waterways with microplastics. In this wide-ranging interview, we talk to the author of Traffication: How Cars Destroy Nature and What We Can Do About It, Paul Donald about how he coined the term "traffication," the history of road ecology, and what we can do about the problem. Credits Host: Alexis Pedrick Senior Producer: Mariel Carr Producer: Rigoberto Hernandez Associate Producer: Sarah Kaplan Audio Engineer: Jonathan Pfeffer “Color Theme” composed by Jonathan Pfeffer. Additional music by Blue Dot Sessions Note to Our Listeners We are aware of an issue with certain podcast players displaying the incorrect length for the episode. We're looking into it and hope to have the matter resolved soon. In the meantime, the actual run time of the episode is the length displayed in the feed before pressing play. We apologize fo

In 1856, Henry Perkin's attempt to synthesize quinine led to something very different: a vibrant purple dye. Perkin’s mauve revolutionized the fashion industry when Queen Victoria wore a dress of the color to her daughter's wedding. And in an ironic twist, synthetic fabric dyes ultimately led to synthetic drugs, including the first antipsychotic. This drug, known by its trade name Thorazine, was a gamechanger. “Nobody thought there could be a drug that would treat schizophrenia effectively,” says sociologist Andrew Scull, “and then suddenly there was.” In this episode we explore the enduring relationship between dyes and drugs, and the role that mistakes and serendipity still play in drug development. Credits Host: Alexis Pedrick Executive Producer: Mariel Carr Producer: Rigoberto Hernandez Associate Producer: Sarah Kaplan Audio Engineer: Jonathan Pfeffer “Color Theme” composed by Jonathan Pfeffer. Additional music by Blue Dot Sessions. Note to Our Listeners We are aware of an issue with certain podcast playe

The color pink has long been in vogue, and when Barbie hit theaters in 2023, its appeal only increased. But its popularity dates back much further than the Mattel doll. In this bonus episode, Dr. Dominique Grisard, a gender studies professor at the University of Basel, discusses the hue and its ties to femininity, class, and Whiteness, as well as how pink has been used to subdue men in detention centers. This episode was inspired by our museum exhibition, BOLD: Color from Test Tube to Textile, on view through August 3, 2024. Credits Host: Alexis Pedrick Senior Producer: Mariel Carr Producer: Rigoberto Hernandez Associate Producer: Sarah Kaplan Audio Engineer: Jonathan Pfeffer “Color Theme” composed by Jonathan Pfeffer. Additional music by Blue Dot Sessions Note to Our Listeners We are aware of an issue with certain podcast players displaying the incorrect length for the episode. We're looking into it and hope to have the matter resolved soon. In the meantime, the actual run time of the episode is the length d

For centuries people have been drawn to the potential healing powers of colored light. From a civil war general to a Thomas Edison wannabe, people have touted it as a medical miracle. Despite claims to the contrary, though, colored light won’t regrow limbs or heal burns. And yet, we are still drawn to the idea that somehow it can fix us. Today there are actual medical studies investigating the health benefits of colored light. So is there any validity to the claims of the past? Can color really heal us? This episode was inspired by our museum exhibition, BOLD: Color from Test Tube to Textile, on view through August 3, 2024. Credits Host: Alexis Pedrick Senior Producer: Mariel Carr Producer: Rigoberto Hernandez Associate Producer: Sarah Kaplan Audio Engineer: Jonathan Pfeffer “Color Theme” composed by Jonathan Pfeffer. Additional music by Blue Dot Sessions Note to Our Listeners We are aware of an issue with certain podcast players displaying the incorrect length for the episode. We're looking into it and hope

In his epic poem, The Odyssey, Homer mentions the colors black, white, red, and yellow. But despite numerous mentions of the brilliant Greek sea and sky, the word blue never makes an appearance.  This omission set off a debate between perception and language that would repeat itself over and over again throughout history: was there something wrong with the ancient Greek’s eyes? If they didn’t name blue, did that mean they couldn’t see it? We treat color like it's a clear measure of whether or not our brains are working the same. We expect an answer we can all agree on. Only it turns out some colors elude us. So when it comes to blue, are we truly seeing things differently or just seeing the same thing and describing it differently? Credits Host: Alexis Pedrick Senior Producer: Mariel Carr Producer: Rigoberto Hernandez Associate Producer: Sarah Kaplan Audio Engineer: Jonathan Pfeffer “Color Theme” composed by Jonathan Pfeffer. Additional music by Blue Dot Sessions Note to Our Listeners We are aware of an issue

Check out our new season, dropping weekly on Tuesdays, starting June 4th.